4.5 Article

Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction

Journal

LIPIDS IN HEALTH AND DISEASE
Volume 20, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12944-021-01478-w

Keywords

Coronary angiography; Coronary artery disease; Premature myocardial infarction; Proprotein convertase subtilisin; kexin type 9

Funding

  1. Key Project of Scientific and Technological Support Plan of Tianjin in 2020 [20YFZCSY00820]
  2. Major Science and Technology Projects of Tianjin Science and Technology Commission in 2016 [16ZXMJSY00150]
  3. National 135 Key Research and Development Program in 2016 [2016YFC1301203]

Ask authors/readers for more resources

This study found a positive association between serum Pcsk9 levels and severity of coronary artery lesion in patients with premature myocardial infarction. High Pcsk9 levels were also identified as an independent predictor for adverse cardiac events.
Background Proprotein convertase subtilisin/kexin type 9 (Pcsk9) correlated with incidence and prognosis of coronary heart disease. However, it is unclear whether Pcsk9 contributed to coronary artery lesion severity in patients with premature myocardial infarction (PMI). The present study investigated associations between Pcsk9 and coronary artery lesion severity in PMI patients who underwent coronary angiography (CAG). Methods This prospective cohort study included young men (age <= 45 years, n = 332) with acute MI who underwent CAG between January 2017 and July 2019. Serum Pcsk9 levels and clinical characteristics were evaluated. SYNTAX scores (SYNergy between percutaneous coronary intervention with [paclitaxel-eluting] TAXUS stent and cardiac surgery) were calculated to quantify coronary artery lesions. Results Serum Pcsk9 levels were positively associated with SYNTAX scores (r = 0.173, P < 0.05). The diagnostic cutoff value of PSCK9 level was 122.9 ng/mL, yielding an area under the curve (AUC) of 0.63, sensitivity 81%, and specificity 40%. Serum Pcsk9, LDL-C, Apob, NT-proBnp, CK level, and diabetes history were independent predictors of high SYNTAX scores (P < 0.05). After stratifying by serum LDL-C level (cutoff = 2.6 mmol/L), medium-high Pcsk9 levels had increased risk of high SYNTAX scores in patients with high LDL-C (P < 0.05), and higher serum Pcsk9 levels had increased risk of major adverse cardiac events (MACE) after adjusting for confounding factors (P < 0.05). Conclusion Serum Pcsk9 levels correlates with severity of coronary artery lesion in PMI patients and may serve as a biomarker for severity of coronary artery stenosis in this patient population, which may contribute to risk stratification.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available